Qube Research & Technologies (QRT)’s Novartis NVS Stock Holding History

Qube Research & Technologies (QRT)’s Portfolio NVS Stock Details NVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$78.4K	Hold	500	–	–	﹤0.01%	3052
2026 Q1	$76.4K	Sell	500 -1,700	-77%	-$261K	﹤0.01%	3111
2025 Q4	$303K	Sell	2,200 -800	-27%	-$105K	﹤0.01%	2947
2025 Q3	$385K	Sell	3,000 -700	-19%	-$85.4K	﹤0.01%	2779
2025 Q2	$448K	Buy	3,700 +900	+32%	+$101K	﹤0.01%	2721
2025 Q1	$312K	Buy	2,800 +1,800	+180%	+$192K	﹤0.01%	2720
2024 Q4	$97.3K	Buy	1,000 +800	+400%	+$85.3K	﹤0.01%	2998
2024 Q3	$23K	Buy	+200	New	+$22.7K	﹤0.01%	2961

Other funds holding NVS

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $79.8B AUM 16.05% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Qube Research & Technologies (QRT)'s NVS Position: Q2 2026 in Review

Qube Research & Technologies (QRT) reduced its Novartis (NVS) stake by 75% in Q2 2026, selling an estimated $19.4M and leaving 43,740 shares worth $6.85M. The position accounts for 0.01% of the portfolio, ranked #1474.

Qube Research & Technologies (QRT) first reported a position in NVS in Q4 2019 and has held it in 22 quarters since. The position peaked at $70.6M in Q1 2024. 1,623 funds tracked by Wall St. Rank hold NVS as of Q2 2026.

Qube Research & Technologies (QRT) held 43,740 shares of Novartis worth $6.85M as of Q2 2026.
Qube Research & Technologies (QRT) sold 129,397 Novartis shares in Q2 2026, an estimated $19.4M.
Novartis made up 0.01% of Qube Research & Technologies (QRT)'s portfolio in Q2 2026, its #1474 holding.
Qube Research & Technologies (QRT) first reported a position in Novartis in Q4 2019 and has held it in 22 quarters since.
Qube Research & Technologies (QRT)'s Novartis position peaked at $70.6M in Q1 2024.
1,623 funds tracked by Wall St. Rank held Novartis as of Q2 2026.

Based on Qube Research & Technologies (QRT)'s 13F filing for Q2 2026, filed 14 Aug 2026.